Oracle’s stock has seen a significant decline since peaking in September, largely tied to how investors are interpreting a metric known as “remaining performance obligations” (RPOs). RPOs indicate contracted sales that have not yet been recognized as revenue, meaning they are based on management’s assessment of future sales potential rather than confirmed income. This metric has taken center stage among investors focused on AI companies, particularly after Oracle reported a staggering increase in RPOs from $455 billion to $523 billion in just a few months. Despite this growth in RPOs, Oracle’s stock has plummeted by 43% from its September high. Investors are skeptical about the sustainability of these RPOs, especially in the context of the AI market's volatility. Concerns have emerged regarding the nature of AI deals and whether companies like OpenAI can fulfill their ambitious commitments. The juxtaposition of soaring RPOs against a backdrop of declining stock value highlights the uncertainty that investors feel about Oracle's future prospects, underscoring the risks tied to relying on such abstract metrics for evaluating company performance.